Skip to main content

Deloitte China assists listing of QingSong Health

Deloitte China assisted QingSong Health Corporation ("QingSong Health", Stock Code: 02661.HK) in its successful listing on the Main Board of The Stock Exchange of Hong Kong Limited ("SEHK") on 23 December 2025.

In this global offering, QingSong Health offered 26.54 million shares for public subscription at an offer price of HKD22.68 per share, raising total proceeds of approximately HKD602 million (before the exercise of over-allotment option).

(From left) William Deng, Audit & Assurance (A&A) manager of Deloitte China; Dick Kay, National leader of Deloitte China’s Capital Market Services Group; Elsie Zhou, partner of Deloitte China’s listing engagement for QingSong Health; Yang Yin, founder, chairlady, executive director, and chief executive officer of QingSong Health; Wang Jing, QingSong Health’s executive director and chief financial officer; Caroline Yang, Technical partner of Deloitte China; and Selina Jiang, Senior manager of A&A of Deloitte China attend the listing ceremony of QingSong Health at Hong Kong Stock Exchange.

(From left) William Deng, Caroline Yang, Natalie Chan, Yang Ying, Wang Jing, Elsie Zhou, Dick Kay and Selina Jiang attend the listing ceremony of QingSong Health at Hong Kong Stock Exchange.

Client overview

QingSong Health is a one-stop platform in China focused on providing integrated digital health services and health insurance solutions. It meets users' comprehensive health needs through personalized integrated solutions, offering a spectrum of services ranging from digital marketing, digital medical research assistance, integrated health service packages, to early disease screening related promotion and consultancy service.

To support users' health expenditures and meet their protection needs, QingSong Health also provides digital integrated insurance services through its internet insurance platform. It offers users health insurance products and coverage plans, while also providing insurance technical support to partner insurance companies to help enhance their operational efficiency and risk management capabilities.

Source: QingSong Health’s IPO prospectus published on 15 December 2025

Deloitte's role

As a core professional service institution in this engagement, Deloitte China was deeply involved throughout the entire process of application, offering, fundraising and listing for QingSong Health. This successful listing demonstrates Deloitte China's professional service capabilities in the capital market. Our engagement team worked in close collaboration with various professional parties. Leveraging rich industry experience and exceptional professional expertise, the team consistently delivered high-quality services to assist QingSong Health in achieving its listing on the Main Board of the SEHK.

Deloitte China congratulates QingSong Health on its successful listing on the SEHK. We will continue to provide high quality professional services and outstanding resources integration to assist more clients stay one-step ahead in today's increasingly competitive and complex business environment.